Detalhe da pesquisa
1.
Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
Cancer Sci
; 111(6): 2183-2195, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32237253
2.
Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
PLoS Genet
; 13(6): e1006853, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28636652
3.
Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes.
Cancer Sci
; 110(9): 2973-2981, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31293054
4.
Mucin 21 is a key molecule involved in the incohesive growth pattern in lung adenocarcinoma.
Cancer Sci
; 110(9): 3006-3011, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31301084
5.
Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
Int J Cancer
; 142(8): 1627-1639, 2018 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29193056
6.
Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
Cancer Sci
; 108(9): 1888-1896, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28677170
7.
Genomic characterization of primary central nervous system lymphoma.
Acta Neuropathol
; 131(6): 865-75, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26757737
8.
Transforming mutations of RAC guanosine triphosphatases in human cancers.
Proc Natl Acad Sci U S A
; 110(8): 3029-34, 2013 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-23382236
9.
Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer.
Cancer Sci
; 106(12): 1687-92, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26432419
10.
Oncogenic activity of BIRC2 and BIRC3 mutants independent of nuclear factor-κB-activating potential.
Cancer Sci
; 106(9): 1137-42, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26094954
11.
Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.
Jpn J Clin Oncol
; 44(6): 593-6, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24688086
12.
Oncogenic mutations of ALK kinase in neuroblastoma.
Nature
; 455(7215): 971-4, 2008 Oct 16.
Artigo
Inglês
| MEDLINE | ID: mdl-18923524
13.
Cancer-associated missense mutations of caspase-8 activate nuclear factor-κB signaling.
Cancer Sci
; 104(8): 1002-8, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23659359
14.
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.
N Engl J Med
; 363(18): 1734-9, 2010 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-20979473
15.
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation.
BMC Cancer
; 13: 262, 2013 May 29.
Artigo
Inglês
| MEDLINE | ID: mdl-23714228
16.
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Nature
; 448(7153): 561-6, 2007 Aug 02.
Artigo
Inglês
| MEDLINE | ID: mdl-17625570
17.
Oncogenic MAP2K1 mutations in human epithelial tumors.
Carcinogenesis
; 33(5): 956-61, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22327936
18.
High-throughput resequencing of target-captured cDNA in cancer cells.
Cancer Sci
; 103(1): 131-5, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21929543
19.
Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
Haematologica
; 96(3): 464-7, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21134980
20.
A mouse model for EML4-ALK-positive lung cancer.
Proc Natl Acad Sci U S A
; 105(50): 19893-7, 2008 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-19064915